Search results
Column: She's 80, washing dishes, and fighting for a better deal for younger workers
LA Times via Yahoo News· 7 days agoSalud Garcia, 80, walks a picket line to fight for higher wages. She won't benefit much, given her...
Column: She's 80, washing dishes, and fighting for a better deal for younger workers
Los Angeles Times· 7 days agoIn the land of killer commutes, Salud Garcia’s trek is such a slog, she should get a gold medal at...
Letter to the editor: Affordable health care in Wisconsin
Kenosha News· 14 hours agoHealth care for all is very important for many reasons. Individuals will be able to see a doctor and get medical treatment. Affordable health care gives many people their necessary medications ...
Psoriatic Arthritis Drugs Comparably Improve Joint Outcomes
Medscape· 4 days agoReal-world study data suggest there is little difference among five drug classes commonly used to...
The False Claims Act and Health Care: 2023 Recoveries and 2024 Outlook
The National Law Review· 4 days agoOn 22 February 2024, the US Department of Justice (DOJ) published the statistics for federal civil...
'Any family considering getting pregnant in Idaho should be aware of what could happen to them.' |...
KTVB Boise· 3 days agoAhead of the Supreme Court's expected decision on Idaho's near-total abortion ban, The 208 is...
COVID-19 Relief Enforcement Actions Highlight Ongoing Risk | JD Supra
JD Supra· 6 days agoThe Department of Justice (DOJ) continues to demonstrate its sustained interest in COVID-19 relief fraud as an enforcement priority and we can expect to see persistent enforcement in this area ...
Gateway - Quartz
Quartz· 5 days agoPharmaceutical giant AbbVie was able to delay competition to its blockbuster arthritis drug, Humira, into the US market for many years. Although biosimilars will sell at a list price lower than ...
Izokibep Enthesitis Benefit Lacking in Phase 2b/3 PsA Trial
Medscape· 4 days agoThe primary efficacy endpoint was met, but the novel small molecule therapeutic did not reduce...
In drug-pricing debate, Mass. gene-therapy drugmakers make their case - Boston Business Journal
The Business Journals· 2 days agoWhen a new gene therapy to treat a deadly rare disease called metachromatic leukodystrophy was approved earlier this year, the first thing on Maria Kefalas’ mind wasn’t the price. Kefalas' daughter ...